1. OCV-S Trial Site, Kanti Children’s Hospital, Kathmandu, Nepal
2. Department of Paediatrics, National Academy of Medical Sciences (NAMS), Kathmandu, Nepal
3. Biostatistics & Data Management Unit, International Vaccine Institute (IVI), Seoul, Korea
4. Science Unit, International Vaccine Institute (IVI), Seoul, Korea
5. Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute (IVI), Seoul, Korea
6. Europe Regional Office Director, International Vaccine Institute (IVI), Seoul, Korea
7. Cholera Program Director, International Vaccine Institute (IVI), Seoul, Korea